Literature DB >> 19767237

Risk estimation for the next generation of prevention programmes for cervical cancer.

Hormuzd A Katki1, Sholom Wacholder, Diane Solomon, Philip E Castle, Mark Schiffman.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19767237      PMCID： PMC2789459          DOI： 10.1016/S1470-2045(09)70253-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  11 in total

1.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.

Authors: 
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

2.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

Authors:  You-Lin Qiao; John W Sellors; Paul S Eder; Yan-Ping Bao; Jeanette M Lim; Fang-Hui Zhao; Bernhard Weigl; Wen-Hua Zhang; Roger B Peck; Ling Li; Feng Chen; Qing-Jing Pan; Attila T Lorincz
Journal:  Lancet Oncol       Date:  2008-09-19       Impact factor: 41.316

Review 3.  New technologies in cervical cancer screening.

Authors:  Patti E Gravitt; François Coutlée; Thomas Iftner; John W Sellors; Wim G V Quint; Cosette M Wheeler
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

Review 4.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 5.  Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.

Authors:  Kate Cuschieri; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

Review 6.  Risk assessment to guide the prevention of cervical cancer.

Authors:  Philip E Castle; Mario Sideri; Jose Jeronimo; Diane Solomon; Mark Schiffman
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

Review 7.  2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

Review 8.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

9.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

10.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245
View more
  17 in total

1.  Performance of common genetic variants in breast-cancer risk models.

Authors:  Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; Stephen J Chanock; David J Hunter
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

Review 2.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

Review 3.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

4.  Clinical utility in evaluation of risk models.

Authors:  Sholom Wacholder
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

5.  Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

6.  Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records.

Authors:  Li C Cheung; Qing Pan; Noorie Hyun; Mark Schiffman; Barbara Fetterman; Philip E Castle; Thomas Lorey; Hormuzd A Katki
Journal:  Stat Med       Date:  2017-06-28       Impact factor: 2.373

7.  Perceived risk of cervical cancer in Appalachian women.

Authors:  Kimberly M Kelly; Amy K Ferketich; Mack T Ruffin Iv; Cathy Tatum; Electra D Paskett
Journal:  Am J Health Behav       Date:  2012-11

Review 8.  The known unknowns of HPV natural history.

Authors:  Patti E Gravitt
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

9.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.

Authors:  Hormuzd A Katki; Walter K Kinney; Barbara Fetterman; Thomas Lorey; Nancy E Poitras; Li Cheung; Franklin Demuth; Mark Schiffman; Sholom Wacholder; Philip E Castle
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

10.  U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality.

Authors:  Marie-Josèphe Horner; Sean F Altekruse; Zhaohui Zou; Louise Wideroff; Hormuzd A Katki; David G Stinchcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-25       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.